WBB's Brozak Discusses Geron's Stem Cell Halt (Audio)

Stephen Brozak, president and co-founder of WBB Securities, discusses Geron Corp. (GERN)'s decision to end its stem cell research program. Brozak talks with Bloomberg's Pimm Fox and Courtney Donohoe on Bloomberg Radio's "Taking Stock."

(Source: Bloomberg)

Running time 08:36

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.